Metabolome Profiling And Molecular Docking Analysis Revealed The Metabolic Differences And Potential Pharmacological Mechanisms Of The Inflorescence And Succulent Stem Of Cistanche Deserticola Part 2
May 22, 2023
3.4 Mapping of differential metabolites related to phenylethanoid glycosides(PhGs)biosynthesis pathway
Previously, we have integrated transcriptomic and metabolomic analysis to explore the biosynthetic pathways of PhGs in the succulent stems of C. deserticola.16 To discover the molecular mechanism leading to the difference in metabolism between inflorescence and succulent stem, we reconstructed the biosynthetic pathway of PhGs (Fig. 4). It mainly contained four KEGG pathways: “phenylpropanoid biosynthesis (Ko00940)”, “phenylalanine, tyrosine and tryptophan biosynthesis (Ko00400)”, “tyrosine metabolism (Ko00350)” and “phenylalanine metabolism (Ko00360)”. The results in Fig. 4 showed that the relative content of compounds in the PhGs biosynthesis pathway varied with the tissues (inflorescences and succulent stems) and ecotypes (saline-alkali land, grassland, and sandy land) of C. deserticola. In the grassland ecotype, the relative contents of tyrosine and cinnamic acid were up-regulated in succulent stems. Both in saline-alkali land and grassland ecotype, the relative contents of caffeic acid were up-regulated in inflorescences. Metabolome analysis detected three phenylethanoid glycosides (PhGs), namely isoacteoside, acteoside, and 2′-acetylacteoside, and their relative content was the highest in the A2 group.
According to relevant studies,cistanche is a common herb that is known as "the miracle herb that prolongs life". Its main component is cistanoside, which has various effects such as antioxidant, anti-inflammatory, and immune function promotion. The mechanism between cistanche and skin whitening lies in the antioxidant effect of cistanche glycosides. Melanin in human skin is produced by the oxidation of tyrosine catalyzed by tyrosinase, and the oxidation reaction requires the participation of oxygen, so the oxygen-free radicals in the body become an important factor affecting melanin production. Cistanche contains cistanoside, which is an antioxidant and can reduce the generation of free radicals in the body, thus inhibiting melanin production.

Click On Cistanche Tubulosa Supplement for Whitening
【For more info: david.deng@wecistanche.com / WhatApp:86 13632399501】
In addition, cistanche also has the function of promoting collagen production, which can increase the elasticity and luster of the skin and help repair damaged skin cells. Cistanche Phenylethanol Glycosides have a significant down-regulating effect on tyrosinase activity, and the effect on tyrosinase is shown to be competitive and reversible inhibition, which can provide a scientific basis for developing and utilizing the whitening ingredients in Cistanche. Therefore, cistanche has a key role in skin whitening. It can inhibit melanin production to reduce discoloration and dullness; and promote collagen production to improve skin elasticity and radiance. Due to the widespread recognition of these effects of cistanche, many skin whitening products have begun to infuse herbal ingredients such as Cistanche to meet consumer demand, thus increasing the commercial value of Cistanche in skin whitening products. In summary, the role of cistanche in skin whitening is crucial. Its antioxidant effect and collagen-producing effect can reduce discoloration and dullness, improve skin elasticity and luster, and thus achieve a whitening effect. Also, the wide application of Cistanche in skin whitening products demonstrates that its role in commercial value cannot be underestimated.
3.5 Molecular docking analysis of the main active components of C. deserticola
The collected 45 related disease targets were molecularly docked with 127 compounds of C. deserticola. Based on the results of literature comparison and molecular docking, 15 marks and 88 compounds were finally screened (Tables S2 and S3). Table S2 showed information about targets, diseases, and predicted genes. To further understand the comprehensive relationship between the selected compounds, selected predicted genes, and diseases, a comprehensive network analysis was performed using Cytoscape version 3.7.0 (Fig. 5a). An intricate network was formed among the selected compounds and their potential targets regarding osteoporosis, vascular disease, atherosclerosis, myocardial injury, Alzheimer disease, Parkinson, ventricular tachycardia, and rectal cancer. The degree of the network on the compound–target interaction was depicted in Table S2, which indicated that the predicted genes CTSK and FDPS related to osteoporosis, and the target gene ACE about vascular disease have a higher degree value, indicating that more compounds in C. deserticola can act on these targets gene.

The interaction between the 12 genes was analyzed and visualized using STRING databases. The protein–protein interaction (PPI) network (Fig. 5b) was constructed under “medium confidence (0.4 by default)”. Using the DAVID database, the 14 KEGG pathways of the 12 predicted genes were visualized in Fig. 5c. The KEGG pathways enriched by these genes mainly include serotonergic synapse, hepatitis B, proteoglycans in cancer, and viral carcinogenesis. The list of the 12 screened predicted genes was uploaded to the DAVID database for GO enrichment analysis (Fig. 5d). The targets were involved in many biological processes (BP) including “platelet activation”, “positive regulation of neuron apoptotic process”, and “hippocampus development”. “Cytosol”, “nucleoplasm”, and “mitochondrion” ranked the highest in the cellular component (CC) category. At the same time “kinase activity”, “protein kinase activity”, and “protein serine/threonine kinase activity” were the primary molecular function (MF) involved.
Table S3 shows the molecular docking results of the effective components of succulent stems of C. deserticola and disease targets. As shown in Fig. 4, 2′-acetylacteoside, acteoside and isoacteoside in PhGs of C. deserticola respond to salt-alkali stress. Fig. 6a and S4a demonstrated a detailed view of the molecular docking of these three compounds with high-scoring targets. 2′-Acetylacteoside had excellent docking with targets related to atherosclerosis (3TL5) and vascular disease (4BZR). Isoacteoside had high score docking with targets related to osteoporosis (4X6H) and vascular disease (4BZR). Acteoside had better docking with targets related to vascular disease (4BZR) and ventricular tachycardia (4GQS). Fig. 6b and S4b showed molecular docking results between four flavonoids detected only in the inflorescence and the selected inflammation targets. Table S4 indicated that chrysoeriol and cynaroside had higher scores with 2 targets.

4. Discussion
Our study indicates the inflorescence of C. deserticola not only contains the main active ingredient PhGs but also contains a large number of flavonoids. In particular, the relative content of flavonoids is significantly higher than the succulent stems. Flavonoids, due to their antioxidant, anti-cancer properties, anti-inflammatory and anti-mutagenic properties, and their ability to regulate the function of key cell enzymes, are now considered essential ingredients in various health foods, medicines, drugs, and cosmetics applications.32 Flavonols are a class of flavonoids with a 3-hydroxy flavonoid skeleton (IUPAC name: 3-hydroxy-2-phenylchromium-4-one). Their diversity stems from the different positions of the phenol-OH group.33 The tautomerism of flavonols causes double fluorescence (due to excited-state intramolecular proton transfer or ESIPT), which can promote UV protection in plants.34 Therefore, we recommend reusing the inflorescences of C. deserticola rich in flavonoids rather than discarding them.

Interestingly, we found that most of the differential metabolites associated with saline-alkali stress in the three ecotypes of C. deserticola were also flavonoids. Our previous research16 found that the relative content of phenylethanoid glycosides (PhGs) in the succulent stems of C. deserticola (saline-alkali land) is higher than the other two ecotypes. Salinity can cause a variety of adverse effects in plants, and one of its inevitable consequences is the excessive production of reactive oxygen species (ROS). Fini et al. believed that flavonoids are an important part of the secondary ROS scavenging system.35 Xu-mei Jia et al. speculated that sucrose signaling regulates ROS homeostasis by inducing phenylpropane biosynthesis pathway and flavonoid synthesis.36 Wang et al. believe that because flavonoids can remove harmful stress response substances (including free radicals, singlet oxygen molecules, and peroxides), they can enhance the tolerance of plants to abiotic and biotic stresses.37 Zhang et al. used transcriptome analysis to reveal the molecular response of Cynanchum auriculatum leaves to salt stress. They found that the biosynthetic pathway of flavonoids and phenylpropanoids was activated. In this pathway, trans-cinnamic acid 4-monooxygenase (C4H) and chalcone isomers are directly related to the synthesis of flavonoids, in which their expression levels of them were all up-regulated. These results indicated that more flavonoids were synthesized, which may contribute to the total antioxidant capacity in response to the saltwater stress of C. auriculatum. Similarly, Walia et al. reported that a large number of genes in the flavonoid biosynthesis pathway were up-regulated under salt stress, which played an important protective role in resisting salt stress.38 In summary, we believe that saline-alkali stress promotes the accumulation of flavonoids in both succulent stems and inflorescences of C. deserticola. We strongly regard saline soil as the best soil type for C. deserticola cultivation.

On the one hand, we obtained the unique flavonoids in the inflorescence by analyzing the results of the metabolome. Considering the role of flavonoids in anti-inflammatory, we carried out molecular docking analysis of these five compounds with inflammation-related targets, to guide the development of non-medicinal inflorescence resources. On the other hand, we carried out molecular docking of the active components of the succulent stems of C. deserticola to make up for the gap in this regard. It provided some directions for the therapeutic mechanism of the active ingredients of C. deserticola for the treatment of aging diseases. Zhang et al. found that C. deserticola extract has potential anti-osteoporosis activity, and this effect is at least partly involved in RANKL/RANK/TRAF6 mediated NF-κB and PI3K/AKT signal transduction and the regulation of c-Fos and NFAT2 levels.39 The published data proved that several isolated compounds of C. deserticola, including echinacoside, acteoside, and cistanoside A, were also reported to be processing anti-osteoporosis activities.40–42 Compounds associated with atherosclerosis-related targets include 2′-acetylacteoside, acteoside, echinacoside, daucosterol, isoacteoside, cistanoside A, arena inside, cistanosinenside A, etc. Though more biological validation is needed to further validate the current results, this work may provide new treatment opportunities for aging diseases such as osteoporosis, atherosclerosis, etc., and may open up new ways for the discovery of drug combinations from the natural products of C. deserticola.

In conclusion, this study is the first to reveal the metabolic variation characteristics between the inflorescences and succulent stems of the three ecotypes of C. deserticola. Moreover, molecular docking was applied to screen the potential therapeutic targets and compounds of C. deserticola. The following conclusions were obtained: (1) the number of metabolites in the inflorescence is more abundant than that of the succulent stems, and most of the metabolites only detected in the inflorescence are flavonoids, which can be used as a material for the development of new medicinal resources. (2) Isorhamnetin O-hexoside and rosinidin O-hexoside can be used as chemical markers to distinguish succulent stems and inflorescences in the three ecotypes. (3) Saline-alkali stress leads to a large accumulation of flavonoids in C. deserticola. We suggest that saline-alkali land is a good choice for cultivating C. deserticola. (4) The active ingredients of C. deserticola have good potential therapeutic effects on aging diseases such as osteoporosis and vascular disease and atherosclerosis. Meanwhile, the unique flavonoids in the inflorescence of C. deserticola have high docking scores with the anti-inflammatory targets, which provides a new direction for the development and utilization of the inflorescence. This research has laid a theoretical foundation for the artificial cultivation and effective resource development of C. deserticola. Our study provides novel methods and theoretical guidance for the development and utilization of new resources of medicinal plants and the discovery of potential therapeutic mechanisms of natural products.
Funding
This work was supported by the National Natural Science Foundation of China (81473315 and U1812403-1), the National Science & Technology Fundamental Resources Investigation Program of China (2018FY100701), the Open Research Fund of Chengdu University of Traditional Chinese Medicine Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China (003109034001) and Beijing Natural Scientific Foundation (7202135), which are gratefully acknowledged.
Author contributions
All authors contributed to the manuscript revision, and read and approved the submitted version. XS, LF-H, and YZ contributed conception and design of the study; XS, PJ, and BA collected the samples; XS and YZ organized the database; XS performed the statistical analysis; XS and LF-H wrote the first draft of the manuscript; LF-H, YZ, JP, and AB wrote sections of the manuscript.
Conflicts of interest
The authors declare no conflict of interest.
Acknowledgments
We express our great thanks to Xiang Zhang from the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, for the guidelines for molecular docking.
References
1 T. Wang, X. Zhang and W. Xie, Am. J. Chin. Med., 2012, 40, 1123–1141.
2 Y. Jiang and P. F. Tu, J. Chromatogr. A, 2009, 1216, 1970–1979.
3 L. Gu, W.-T. Xiong, C. Wang, H.-X. Sun, G.-F. Li and X. Liu, Asian J. Androl., 2013, 15, 838.
4 N. A. Stefanova, A. Z. Fursova, K. N. Sarsenbaev and N. G. Kolosova, J. Ethnopharmacol., 2011, 138, 624–632.
5 C. Gu, X. Yang and L. Huang, Front. Pharmacol., 2016, 7, 289.
6 S. Zheng, X. Jiang, L. Wu, Z. Wang and L. Huang, PLoS One, 2014, 9, e98061.
7 X. J. Qin, W. Ni, C. X. Chen and H. Y. Liu, Nat. Prod. Bioprospect., 2018, 8, 265–278.
8 F. Yang, Y. Qi, W. Liu, J. Li, D. Wang, L. Fang and Y. Zhang, Molecules, 2019, 24(19), 3448.
9 H. L. Qiao, P. F. Lu, R. Xu, J. Chen, X. Wang, W. S. Ma and T. N. Liu, Zhongyaocai, 2012, 35, 573–577.
10 X. Peng, Y. Luo, J. Wang, T. Ji, L. Yuan and G. Kai, Food Res. Int., 2020, 138, 109799.
11 E. Gemperline, C. Keller and L. Li, Anal. Chem., 2016, 88, 3422–3434.
12 B. Worley and R. Powers, Curr. Metabolomics, 2013, 1, 92– 107.
13 S. Wei, X. Yang, G. Huo, G. Ge, H. Liu, L. Luo, J. Hu, D. Huang and P. Long, Int. J. Mol. Sci., 2020, 21, 1481.
14 J. Xu, J. Yan, W. Li, Q. Wang, C. Wang, J. Guo, D. Geng, Q. Guan and F. Ma, Int. J. Mol. Sci., 2020, 21, 4797.
15 W. Xin, L. Zhang, W. Zhang, J. Gao, J. Yi, X. Zhen, M. Du, Y. Zhao and L. Chen, Int. J. Mol. Sci., 2019, 20, 5893.
16 X. Sun, L. Li, J. Pei, C. Liu and L.-F. Huang, Plant Mol. Biol., 2020, 102, 253–269.
17 W. Liu, Q. Song, Y. Cao, N. Xie, Z. Li, Y. Jiang, J. Zheng, P. Tu, Y. Song and J. Li, J. Pharm. Biomed. Anal., 2019, 162, 16–27.
18 P. Zou, Y. Song, W. Lei, J. Li, P. Tu and Y. Jiang, Acta Pharm. Sin. B, 2017, 7, 647–656.
19 S. Li and B. Zhang, Chin. J. Nat. Med., 2013, 11, 110–120.
20 X. Zhang, D. Wang, X. Ren, A. G. Atanasov, R. Zeng and L. Huang, Curr. Protein Pept. Sci., 2019, 20, 964–975.
21 W. Wu, Z. Zhang, F. Li, Y. Deng, M. Lei, H. Long, J. Hou and W. Wu, Int. J. Mol. Sci., 2020, 21, 1766.
22 J. Liu, J. Zhu, J. Xue, Z. Qin, F. Shen, J. Liu, X. Chen, X. Li, Z. Wu, W. Xiao, C. Zheng and Y. Wang, Sci. Rep., 2017, 7, 16364.
23 Y. Q. Li, Y. Chen, J. Y. Fang, S. Q. Jiang, P. Li and F. Li, J. Ethnopharmacol., 2020, 254, 112764.
24 L. Gu, W. T. Xiong, C. Wang, H. X. Sun, G. F. Li and X. Liu, Asian J. Androl., 2013, 15, 838–840.
25 Z. Li, H. Lin, L. Gu, J. Gao and C. M. Tzeng, Front. Pharmacol., 2016, 7, 41.
26 T. Wang, X. Zhang and W. Xie, Am. J. Chin. Med., 2012, 40, 1123–1141.
27 J. Stamos, M. X. Sliwkowski and C. Eigenbrot, J. Biol. Chem., 2002, 277, 46265–46272.
28 P. A. Harris, M. Cheung, R. N. Hunter, 3rd, M. L. Brown, J. M. Veal, R. T. Nolte, L. Wang, W. Liu, R. M. Crosby, J. H. Johnson, A. H. Epperly, R. Kumar, D. K. Luttrell and J. A. Stafford, J. Med. Chem., 2005, 48, 1610–1619.
29 J. Cheung, M. J. Rudolph, F. Burshteyn, M. S. Cassidy, E. N. Gary, J. Love, M. C. Franklin and J. J. Height, J. Med. Chem., 2012, 55, 10282–10286.
30 M. Koˇz´ıˇsek, M. Lepˇs´ık, K. Grantz ˇSaˇskov´a, J. Brynda, J. Konvalinka and P. Rez´aˇcov´a, FEBS J., 2014, 281, 1834–1847.
31 D. Szklarczyk, A. L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, M. Simonovic, N. T. Doncheva, J. H. Morris, P. Bork, L. J. Jensen and C. V. Mering, Nucleic Acids Res., 2019, 47, D607–D613.
32 A. Panche, A. Diwan and S. Chandra, J. Nutr. Sci., 2016, 5, e47. 33 J. B. Harborne and C. A. Williams, The flavonoids, Springer, 1975, pp. 376–441.
34 G. J. Smith and K. R. Markham, J. Photochem. Photobiol., A, 1998, 118, 99–105.
35 A. Fini, C. Brunetti, M. Di Ferdinando, F. Ferrini and M. Tattini, Plant Signaling Behav., 2011, 6, 709–711.
36 X. M. Jia, Y. F. Zhu, Y. Hu, R. Zhang, L. Cheng, Z. L. Zhu, T. Zhao, X. Zhang and Y. X. Wang, Hortic. Res., 2019, 6, 91.
37 F. Wang, W. Kong, G. Wong, L. Fu, R. Peng, Z. Li and Q. Yao, Mol. Genet. Genomics, 2016, 291, 1545–1559.
38 H. Walia, C. Wilson, P. Condamine, X. Liu, A. M. Ismail, L. Zeng, S. I. Wanamaker, J. Mandal, J. Xu, X. Cui and T. J. Close, Plant Physiol., 2005, 139, 822–835.
39 B. Zhang, L.-L. Yang, S.-Q. Ding, J.-J. Liu, Y.-H. Dong, Y.-T. Li, N. Li, X.-J. Zhao, C.-L. Hu and Y. Jiang, Front. Pharmacol., 2019, 10, 1412.
40 F. Li, X. Yang, Y. Yang, C. Guo, C. Zhang, Z. Yang and P. Li, Phytomedicine, 2013, 20, 549–557.
41 S.-Y. Lee, K.-S. Lee, S. H. Yi, S.-H. Kook and J.-C. Lee, PLoS One, 2013, 8, e80873.
42 X. Xu, Z. Zhang, W. Wang, H. Yao and X. Ma, Molecules, 2017, 22, 197.
【For more info: david.deng@wecistanche.com / WhatApp:86 13632399501】






